Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
526 |
|
| Actual shortage: | 144 (27%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 381 (72%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
77 (53%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-SIMVASTATIN | 40MG | TABLET TABLET | Resolved | 2022-02-14 | 2022-06-13 | 154979 |
| JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-09-26 | 169425 |
| JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-10-24 | 169449 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-07 | 2022-10-15 | 171344 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-07 | 2022-10-15 | 171347 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-11-09 | 2023-04-03 | 174059 |
| JAMP TELMISARTAN | 40MG | TABLET | Resolved | 2022-11-09 | 2023-01-10 | 174099 |
| JAMP-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-01-09 | 2023-02-03 | 180253 |
| JAMP ROSUVASTATIN CALCIUM | 40MG | TABLET | Resolved | 2023-01-09 | 2023-02-09 | 180289 |
| JAMP ATORVASTATIN CALCIUM | 40MG | TABLET | Resolved | 2023-02-06 | 2023-03-11 | 183651 |
| JAMP OLMESARTAN | 40MG | TABLET | Resolved | 2023-02-06 | 2023-03-11 | 183674 |
| JAMP-PRAVASTATIN | 40MG | TABLET | Resolved | 2023-02-06 | 2023-04-03 | 183677 |
| CITALOPRAM | 40MG | TABLET | Resolved | 2023-02-06 | 2023-04-03 | 183756 |
| JAMP ELETRIPTAN | 40MG | TABLET | Resolved | 2023-10-18 | 2024-04-29 | 207344 |
| JAMP POSACONAZOLE | 40MG | SUSPENSION | Actual shortage | 2023-11-29 | 2024-04-29 | 211801 |
| JAMP PIOGLITAZONE | 45MG | TABLET | Resolved | 2017-11-21 | 2019-07-08 | 30031 |
| JAMP PIOGLITAZONE | 45MG | TABLET | Actual shortage | 2021-04-07 | 2023-03-11 | 137078 |
| JAMP-CHOLESTYRAMINE | 4G | POWDER FOR SUSPENSION | Actual shortage | 2023-11-28 | 2024-02-06 | 211780 |
| JAMP-CANDESARTAN | 4MG | TABLET | Actual shortage | 2017-03-20 | 2020-02-18 | 3567 |
| JAMP-ONDANSETRON | 4MG | TABLET | Resolved | 2017-12-22 | 2018-04-28 | 34187 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14